within Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AB05_Paroxetine;

model Paroxetine
  extends Pharmacolibrary.Drugs.ATC.N.N06AB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N06AB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Paroxetine is a selective serotonin reuptake inhibitor (SSRI) commonly used for the treatment of major depressive disorder, anxiety disorders, obsessive-compulsive disorder, and other mood disorders. It is an approved and widely-used antidepressant.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Hanif, N, et al., &amp; Rasool, MF (2023). Clinical pharmacokinetics of nebivolol: a systematic review. <i>Drug metabolism reviews</i> 55(4) 428–440. DOI:<a href=\"https://doi.org/10.1080/03602532.2023.2271195\">10.1080/03602532.2023.2271195</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37849071/\">https://pubmed.ncbi.nlm.nih.gov/37849071</a></p></li><li><p>Hu, Z, et al., &amp; Zhou, S (2005). Herb-drug interactions: a literature review. <i>Drugs</i> 65(9) 1239–1282. DOI:<a href=\"https://doi.org/10.2165/00003495-200565090-00005\">10.2165/00003495-200565090-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15916450/\">https://pubmed.ncbi.nlm.nih.gov/15916450</a></p></li><li><p>Hiemke, C (1994). [Paroxetine: pharmacokinetics and pharmacodynamics]. <i>Fortschritte der Neurologie-Psychiatrie</i> 62 Suppl 1 2–8. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7959522/\">https://pubmed.ncbi.nlm.nih.gov/7959522</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Paroxetine;
